192 related articles for article (PubMed ID: 30189291)
1. Genetic variants in major depressive disorder: From pathophysiology to therapy.
Gonda X; Petschner P; Eszlari N; Baksa D; Edes A; Antal P; Juhasz G; Bagdy G
Pharmacol Ther; 2019 Feb; 194():22-43. PubMed ID: 30189291
[TBL] [Abstract][Full Text] [Related]
2. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.
Noordam R; Avery CL; Visser LE; Stricker BH
Pharmacogenomics; 2016 Jun; 17(9):1029-40. PubMed ID: 27248517
[TBL] [Abstract][Full Text] [Related]
3. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association studies in pharmacogenomics of antidepressants.
Lin E; Lane HY
Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
[TBL] [Abstract][Full Text] [Related]
5. Gene × environment interactions in the prediction of response to antidepressant treatment.
Klengel T; Binder EB
Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
[TBL] [Abstract][Full Text] [Related]
6. Progress and prospects in pharmacogenetics of antidepressant drugs.
Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
[TBL] [Abstract][Full Text] [Related]
7. Prospects for personalization of depression treatment with genome sequencing.
Borczyk M; Piechota M; Rodriguez Parkitna J; Korostynski M
Br J Pharmacol; 2022 Sep; 179(17):4220-4232. PubMed ID: 33786859
[TBL] [Abstract][Full Text] [Related]
8. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics with antidepressants in the STAR*D study.
Lin E; Chen PS
Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics, depression and antidepressant treatment.
Menke A; Klengel T; Binder EB
Curr Pharm Des; 2012; 18(36):5879-89. PubMed ID: 22681167
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.
Islam F; Gorbovskaya I; Müller DJ
Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403
[TBL] [Abstract][Full Text] [Related]
12. Environmental and genetic determinants of childhood depression: The roles of DAT1 and the antenatal environment.
D'Souza S; Thompson JM; Slykerman R; Marlow G; Wall C; Murphy R; Ferguson LR; Mitchell EA; Waldie KE
J Affect Disord; 2016 Jun; 197():151-8. PubMed ID: 26991370
[TBL] [Abstract][Full Text] [Related]
13. Gene expression: biomarker of antidepressant therapy?
Menke A
Int Rev Psychiatry; 2013 Oct; 25(5):579-91. PubMed ID: 24151803
[TBL] [Abstract][Full Text] [Related]
14. Gene-environment interaction in major depression and antidepressant treatment response.
Keers R; Uher R
Curr Psychiatry Rep; 2012 Apr; 14(2):129-37. PubMed ID: 22198824
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females.
Shi Y; Yuan Y; Xu Z; Pu M; Wang C; Zhang Y; Liu Z; Wang C; Li L; Zhang Z
J Affect Disord; 2012 Feb; 136(3):558-66. PubMed ID: 22119081
[TBL] [Abstract][Full Text] [Related]
17. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
Helton SG; Lohoff FW
Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
[TBL] [Abstract][Full Text] [Related]
18. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
Unschuld PG; Ising M; Roeske D; Erhardt A; Specht M; Kloiber S; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Jun; 35(7):1583-92. PubMed ID: 20237460
[TBL] [Abstract][Full Text] [Related]
19. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics in depression and antidepressants.
Bondy B
Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
